Times are changing. Increasing competition, regulatory scrutiny and tightening margins are a few of the challenges facing Life Sciences Companies. As a result, drug and device manufacturers are evaluating every aspect of their operations to identify opportunities for greater efficiency and productivity.
From SMBs to global enterprises, life sciences companies have learned to accept a certain level of operational inefficiency. Traditionally, different locations or departments had autonomy when it came to choosing and implementing software, resulting in a patchwork of vendors and products rather than a smoothly integrated system.
It seems around every corner there is data that suggests growth in cloud solutions is staggering. In their most recent report on "state of the cloud", June 2015, Bessemer Venture Partners, who invest in and have a significant portfolio of cloud solutions, indicated a tipping point has been reached where cloud CRM usage, for example, has surpassed on-premise CRM for the first time in history (more than 50% of CRM is now provisioned as cloud solutions).